Steven Reichling is CFO at Accelerate Diagnostics, Inc (AXDX). They have made 14 open-market trades across 1 company since 2015, most recently 2023-03-13.
CIK 0001556290
5 open-market purchases totalling $45K since 2015, against 9 sales. Across 5 scored buys the stock is up 23.6% at ninety days, and 18.6 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| AXDX | 147,078 | $5K |
Shares reported on the most recent Form 4, priced at the 2023-03-15 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 40% | 60% |
| Avg Move | +1.9% | +4.9% | +23.6% |
| Alpha | +3.8% | +5.9% | +18.6% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AXDX | SELL | 2023-03-13 | 2023-03-15 | $0.49 | $2K | -6.5% | +23.5% | +47.8% |
| AXDX | SELL | 2023-03-08 | 2023-03-13 | $0.47 | $30K | -7.5% | +25.1% | +94.3% |
| AXDX | SELL | 2023-02-13 | 2023-02-15 | $0.60 | $3K | -17.7% | -22.6% | +24.2% |
| AXDX | SELL | 2023-01-13 | 2023-01-17 | $0.69 | $3K | -3.8% | -22.3% | -1.2% |
| AXDX | BUY | 2022-08-22 | 2022-08-22 | $1.39 | $7K | +14.3% | +12.2% | -37.4% |
| AXDX | SELL | 2022-04-28 | 2022-04-28 | $0.98 | $29K | -26.4% | -37.9% | +44.9% |
| AXDX | SELL | 2021-05-13 | 2021-05-14 | $6.76 | $112K | -0.9% | +29.7% | -7.0% |
| AXDX | SELL | 2020-12-17 | 2021-02-03 | $7.37 | $6K | +22.3% | -13.5% | -33.7% |
| AXDX | SELL | 2020-11-09 | 2020-11-12 | $9.50 | $747K | -5.1% | -16.3% | +45.4% |
| AXDX | BUY | 2020-03-19 | 2020-03-19 | $6.92 | $7K | +26.6% | +43.0% | +78.6% |
| AXDX | BUY | 2018-11-27 | 2018-11-28 | $13.13 | $11K | -2.4% | -16.0% | +49.3% |
| AXDX | BUY | 2018-11-08 | 2018-11-13 | $14.72 | $11K | -12.7% | -13.6% | +28.9% |
| AXDX | SELL | 2017-06-21 | 2017-06-23 | $28.90 | $867K | -11.2% | -9.9% | -24.0% |
| AXDX | BUY | 2015-09-29 | 2015-10-01 | $15.23 | $9K | -16.3% | -1.1% | -1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.